175 related articles for article (PubMed ID: 38158714)
1. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation.
Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C
Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714
[TBL] [Abstract][Full Text] [Related]
2. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
4. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
6. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages.
Dong M; Zhang X; Peng P; Chen Z; Zhang Y; Wan L; Xiang W; Liu G; Guo Y; Xiao Q; Wang B; Guo D; Zhu M; Yu X; Wan F
Cancer Lett; 2024 May; 590():216801. PubMed ID: 38479552
[TBL] [Abstract][Full Text] [Related]
7. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
10. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
11. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
[TBL] [Abstract][Full Text] [Related]
12. Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells.
Seguin L; Odouard S; Corlazzoli F; Haddad SA; Moindrot L; Calvo Tardón M; Yebra M; Koval A; Marinari E; Bes V; Guérin A; Allard M; Ilmjärv S; Katanaev VL; Walker PR; Krause KH; Dutoit V; Sarkaria JN; Dietrich PY; Cosset É
Commun Biol; 2021 Jun; 4(1):718. PubMed ID: 34112916
[TBL] [Abstract][Full Text] [Related]
13. The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies.
Ryskalin L; Gaglione A; Limanaqi F; Biagioni F; Familiari P; Frati A; Esposito V; Fornai F
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387280
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.
Mao XG; Yan M; Xue XY; Zhang X; Ren HG; Guo G; Wang P; Zhang W; Huo JL
Lab Invest; 2011 Jul; 91(7):1068-78. PubMed ID: 21483406
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.
Sgubin D; Wakimoto H; Kanai R; Rabkin SD; Martuza RL
Stem Cells Transl Med; 2012 Apr; 1(4):322-32. PubMed ID: 23197811
[TBL] [Abstract][Full Text] [Related]
16. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
17. miR-504 modulates the stemness and mesenchymal transition of glioma stem cells and their interaction with microglia via delivery by extracellular vesicles.
Bier A; Hong X; Cazacu S; Goldstein H; Rand D; Xiang C; Jiang W; Ben-Asher HW; Attia M; Brodie A; She R; Poisson LM; Brodie C
Cell Death Dis; 2020 Oct; 11(10):899. PubMed ID: 33093452
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
[TBL] [Abstract][Full Text] [Related]
19. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
[TBL] [Abstract][Full Text] [Related]
20. USF1/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion.
Zhou Y; Meng X; He W; Li X; Zhao R; Dong C; Yuan D; Yang J; Zhang R; Shi G; Huang Y; Liu J; Liu J; Liu S; Fu P; Sun M
Neuro Oncol; 2022 Sep; 24(9):1482-1493. PubMed ID: 35287174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
